Therapeutics Market is projected to be valued at USD 962.4 million in 2025, reaching USD 1,523.4 million by 2035, with a compound annual growth rate (CAGR) of 4.7% during the forecast period. The ...

NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.